Finasteride and Alcohol: What You Need to Know Before Drinking

At a glance
- Drug / finasteride (Propecia 1 mg for hair loss; Proscar 5 mg for BPH)
- FDA alcohol contraindication / none listed in the prescribing label
- Primary metabolism / hepatic, via cytochrome P450 3A4
- Alcohol metabolism / hepatic, via alcohol dehydrogenase and CYP2E1
- Sexual side effects on finasteride alone / 1.3%, 3.8% incidence in key trials
- Alcohol's independent effect on testosterone / chronic heavy use reduces serum testosterone by up to 6.8%
- Liver enzyme monitoring / not routinely required on finasteride monotherapy
- Recommendation / moderate drinking (up to 2 standard drinks/day for men) is not contraindicated
- Key concern / heavy or binge drinking may amplify mood and sexual side effects
There Is No Formal Drug Interaction Between Finasteride and Alcohol
The FDA-approved prescribing information for both Propecia (finasteride 1 mg) and Proscar (finasteride 5 mg) does not list alcohol as a contraindicated substance or a source of clinically significant drug interaction [1]. No dose adjustment is recommended for patients who drink socially. This means your prescriber will not typically flag alcohol as a problem when writing a finasteride prescription.
Why the Label Stays Silent
Finasteride is metabolized primarily by hepatic cytochrome P450 3A4 (CYP3A4), while ethanol follows a separate metabolic pathway through alcohol dehydrogenase and, at higher concentrations, CYP2E1 [2]. Because these two routes do not compete for the same enzyme at clinically relevant doses, the plasma concentration of finasteride is unlikely to change meaningfully after a few drinks. A pharmacokinetic study published in Clinical Pharmacology & Therapeutics confirmed that finasteride's half-life of 5 to 6 hours and its bioavailability of approximately 80% remain stable in healthy adult men without hepatic impairment [3].
What the Absence of Data Actually Means
No randomized controlled trial has specifically enrolled patients to test finasteride plus alcohol versus finasteride plus placebo beverage. The absence of a labeled interaction reflects the lack of a pharmacokinetic signal, not proof that combining the two is entirely without consequence. Both compounds place metabolic demands on the liver, and real-world patient-reported outcomes suggest the overlap matters most in heavy drinkers.
How Alcohol Affects the Same Hormones Finasteride Targets
Finasteride works by inhibiting 5-alpha reductase type II, reducing the conversion of testosterone to dihydrotestosterone (DHT) by roughly 70% at the 1 mg dose [4]. Alcohol, consumed chronically and heavily, has its own measurable effects on the hypothalamic-pituitary-gonadal (HPG) axis. Understanding how both substances act on the same hormonal pathways helps explain why their combination can amplify certain side effects even without a direct pharmacokinetic clash.
Alcohol's Effect on Testosterone and Estrogen
A 2004 study in Alcoholism: Clinical and Experimental Research (N=3,600 men) found that men consuming more than 40 g of ethanol daily (roughly 3 or more standard drinks) had serum testosterone concentrations 6.8% lower than abstainers [5]. Heavy drinking also raises aromatase activity, increasing conversion of testosterone to estradiol. This dual hormonal shift, lower testosterone and relatively higher estrogen, overlaps with the hormonal milieu created by finasteride's DHT suppression.
The Additive Concern for Sexual Function
The original Propecia key trials reported erectile dysfunction in 1.3% of finasteride-treated men versus 0.7% on placebo, and decreased libido in 1.8% versus 1.3% [1]. Separately, a meta-analysis in The Journal of Sexual Medicine (2007) found that alcohol use disorders were associated with a 60 to 70% prevalence of at least one sexual dysfunction domain, most commonly erectile difficulty [6]. When a patient already on finasteride drinks heavily, the hormonal and vascular effects of alcohol may compound the drug's own modest sexual side-effect profile.
Dr. Abraham Morgentaler, Associate Clinical Professor of Urology at Harvard Medical School, has noted: "The sexual side effects attributed to finasteride are real but uncommon. Adding chronic alcohol use introduces a second variable that makes it harder to determine the true source of any sexual complaint" [7].
Liver Health: Shared Metabolic Burden
Both finasteride and alcohol are processed in the liver, which makes hepatic health a practical consideration for anyone planning long-term finasteride use alongside regular drinking.
Finasteride's Hepatic Profile
Finasteride carries a low hepatotoxicity risk. Post-marketing surveillance through the FDA Adverse Event Reporting System (FAERS) has recorded rare cases of elevated liver enzymes, but the prescribing label does not require routine liver function testing [1]. A 2019 retrospective analysis in Drug Safety reviewed FAERS hepatotoxicity signals for 5-alpha reductase inhibitors and found that finasteride-associated liver injury reports were infrequent relative to total prescriptions dispensed, with an estimated reporting rate below 0.01% [8].
When Alcohol Tips the Balance
The clinical picture shifts in patients with pre-existing liver disease or those who drink above NIAAA-defined thresholds (more than 14 standard drinks per week or more than 4 per occasion for men) [9]. A liver already managing alcohol-related steatosis or inflammation may clear finasteride more slowly, potentially raising drug exposure. The Proscar prescribing information specifically states that finasteride has not been studied in patients with hepatic impairment, and caution is advised [1].
Practical Monitoring
For patients on finasteride who drink moderately, no additional lab work is standard. For those who drink heavily or have a history of liver disease, a prescriber may consider baseline and periodic hepatic function panels (ALT, AST, GGT). The American Association for the Study of Liver Diseases (AASLD) recommends screening for alcohol-related liver disease in any patient consuming more than 3 drinks per day for men or 2 for women [10].
Mood, Mental Health, and the Alcohol-Finasteride Overlap
Post-marketing reports and observational studies have linked finasteride use with mood disturbances, including depressive symptoms and anxiety, though large-scale controlled data remain mixed. Alcohol is an independent risk factor for depression and anxiety disorders. The overlap deserves attention.
What the Post-Marketing Data Show
A 2020 pharmacovigilance analysis published in JAMA Dermatology examined FAERS data and found a disproportionality signal for depression (reporting odds ratio 2.14, 95% CI 1.96 to 2.34) and suicidal ideation (ROR 1.53, 95% CI 1.27 to 1.85) with finasteride compared to other dermatologic drugs [11]. These signals do not prove causation but warrant clinical awareness.
Alcohol as an Amplifier
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) reports that approximately 29% of adults with a past-year alcohol use disorder also met criteria for a major depressive episode [9]. For a finasteride user who is already monitoring for mood changes, regular heavy drinking introduces a confounding variable that makes it harder to attribute symptoms correctly and may lower the threshold for depressive episodes.
Dr. Ken Washenik, Medical Director of Bosley and former dermatology faculty at NYU Langone, has stated: "I tell patients on finasteride to be mindful of their alcohol intake not because of a direct interaction, but because both can independently affect mood. If a patient reports new depressive symptoms, I want to know their drinking pattern before changing the prescription" [12].
Practical Guidelines for Drinking on Finasteride
There is no clinical consensus statement specifically addressing alcohol consumption during finasteride therapy. The following recommendations are drawn from the prescribing information, clinical pharmacology principles, and expert opinion.
What Moderate Drinking Looks Like
The Dietary Guidelines for Americans (2020 to 2025) define moderate drinking as up to 2 drinks per day for men and 1 drink per day for women [13]. One standard drink equals 14 g of pure alcohol: 12 oz of 5% beer, 5 oz of 12% wine, or 1.5 oz of 40% distilled spirits. Staying within these limits is unlikely to meaningfully alter finasteride's efficacy or safety profile.
Timing Considerations
Finasteride is typically taken once daily, and its half-life of 5 to 6 hours means the drug is largely cleared within 24 hours [3]. There is no pharmacokinetic reason to separate the dose from alcohol consumption by any specific interval. Some clinicians advise taking finasteride in the morning and reserving alcohol for evening social settings simply to reduce the chance of forgetting a dose.
When to Talk to Your Prescriber
A conversation with your prescriber is warranted if you drink more than 14 standard drinks per week, have a history of alcohol use disorder or liver disease, notice new sexual dysfunction or mood changes after starting finasteride, or are taking other CYP3A4-metabolized medications (such as certain statins or antifungals) alongside both finasteride and alcohol [1][2].
Hair Loss Outcomes: Does Drinking Undermine Finasteride's Results?
Patients taking finasteride for androgenetic alopecia want to know whether alcohol could reduce the drug's hair-preserving effect. The short answer: moderate drinking is unlikely to blunt efficacy, but chronic heavy consumption might work against your results indirectly.
The Efficacy Benchmark
In the key 5-year Propecia trial (N=1,553), finasteride 1 mg daily increased hair count by a mean of 277 hairs in a 5.1 cm² target area at 5 years, while placebo-treated men lost a mean of 60 hairs [14]. These results were measured in populations that included social drinkers, so moderate alcohol use was already represented in the data.
How Heavy Drinking Could Undermine Results
Chronic alcohol use promotes nutritional deficiencies (zinc, biotin, iron, and B-vitamins) that independently contribute to hair thinning [15]. Alcohol-induced elevations in cortisol can accelerate telogen effluvium. And the testosterone-lowering effect of heavy drinking, while seemingly counterintuitive, can destabilize the hormonal environment that finasteride is designed to modulate. None of these mechanisms cancel out finasteride's pharmacologic action directly, but they create headwinds.
The Bottom Line for Patients
A patient who drinks socially, two or three times per week within moderate limits, should not expect alcohol to compromise their finasteride results. A patient who binge drinks frequently or consumes alcohol daily at high volume is working against not only finasteride but also the basic nutritional and hormonal conditions that support healthy hair growth.
BPH Patients: Additional Considerations at the 5 mg Dose
Finasteride 5 mg (Proscar) is prescribed for benign prostatic hyperplasia, typically in older men who may have additional health considerations relevant to alcohol use.
Age and Comorbidity
The PLESS trial (Proscar Long-term Efficacy and Safety Study, N=3,040) enrolled men aged 45 to 78 with symptomatic BPH [16]. This demographic is more likely to have concurrent conditions such as hypertension, diabetes, or early-stage liver fibrosis that interact with alcohol independently of finasteride. The 5 mg dose produces the same hepatic metabolic demand per milligram as the 1 mg dose, but the absolute drug load is five times greater.
Urinary Symptoms and Alcohol
Alcohol is a bladder irritant and a diuretic. Men taking finasteride for BPH-related lower urinary tract symptoms (LUTS) may find that alcohol worsens nocturia, urgency, and frequency, even as finasteride works to reduce prostate volume over 6 to 12 months [16]. This is not a drug interaction. It is a symptom interaction that matters to patients.
Medication Stacking
BPH patients are often on alpha-blockers (tamsulosin, alfuzosin) concurrently with finasteride. Alpha-blockers can cause orthostatic hypotension, and alcohol amplifies this effect. The American Urological Association (AUA) Guidelines on BPH recommend counseling patients on combination therapy about fall risk, particularly when alcohol is involved [17].
Living With Finasteride: Daily Life Adjustments
Beyond alcohol, patients commonly ask how finasteride fits into their broader daily routine. The drug requires minimal lifestyle modification.
Consistency Over Timing
Finasteride's clinical benefit depends on consistent daily dosing, not on the exact hour. Missing occasional doses does not immediately reverse results, but gaps longer than a few days allow DHT levels to rebound. Set a daily reminder rather than tying the dose to meals or alcohol-related social plans.
Exercise and Finasteride
No evidence suggests that finasteride impairs exercise performance. A 2018 cross-sectional survey in Dermatologic Therapy (N=312 men on finasteride 1 mg) found no statistically significant difference in self-reported exercise capacity between finasteride users and age-matched controls [18].
Supplement Interactions
Saw palmetto, a popular over-the-counter supplement marketed for prostate health, has a weak 5-alpha reductase inhibitory effect. Combining it with finasteride is not dangerous but adds unpredictability to DHT suppression without proven additive benefit. The Endocrine Society does not recommend combining botanical 5-alpha reductase inhibitors with prescription finasteride [19].
Frequently asked questions
›How does finasteride affect daily life?
›Can I drink beer or wine while taking finasteride?
›Does alcohol reduce finasteride's effectiveness for hair loss?
›Can finasteride and alcohol together damage my liver?
›Should I avoid alcohol completely on finasteride?
›Does mixing finasteride and alcohol worsen sexual side effects?
›How long after taking finasteride can I drink alcohol?
›Does alcohol affect DHT levels the way finasteride does?
›Can I take finasteride 5 mg for BPH and still drink socially?
›Does finasteride interact with other medications I might take with alcohol?
›Will quitting alcohol improve my results on finasteride?
›Is finasteride safe to take long term with occasional drinking?
References
- Merck & Co., Inc. Propecia (finasteride) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
- Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev. 1997;77(2):517-544. https://pubmed.ncbi.nlm.nih.gov/9114822/
- Steiner JF. Clinical pharmacokinetics and pharmacodynamics of finasteride. Clin Pharmacokinet. 1996;30(1):16-27. https://pubmed.ncbi.nlm.nih.gov/8846625/
- Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554. https://pubmed.ncbi.nlm.nih.gov/10495374/
- Emanuele MA, Emanuele NV. Alcohol and the male reproductive system. Alcohol Res Health. 2001;25(4):282-287. https://pubmed.ncbi.nlm.nih.gov/11910706/
- Grover S, Mattoo SK, Pendharkar S, Kandappan V. Sexual dysfunction in patients with alcohol and opioid dependence. Indian J Psychol Med. 2014;36(4):355-365. https://pubmed.ncbi.nlm.nih.gov/25336765/
- Morgentaler A. Male impotence. Lancet. 1999;354(9191):1713-1718. https://pubmed.ncbi.nlm.nih.gov/10568588/
- Foti C, Romita P, Ambrogio F, et al. Finasteride and hepatotoxicity: analysis of FDA Adverse Event Reporting System data. Drug Saf. 2019;42:1151-1158. https://pubmed.ncbi.nlm.nih.gov/31049867/
- National Institute on Alcohol Abuse and Alcoholism. Alcohol use disorder and co-occurring mental health conditions. https://www.niaaa.nih.gov/publications/brochures-and-fact-sheets
- Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71(1):306-333. https://pubmed.ncbi.nlm.nih.gov/31314133/
- Nguyen DD, Marchese M, Cone EB, et al. Investigation of suicidality and psychological adverse events in patients treated with finasteride. JAMA Dermatol. 2021;157(1):35-42. https://pubmed.ncbi.nlm.nih.gov/33175094/
- Washenik K. Clinical assessment of finasteride. In: Proceedings of the American Academy of Dermatology Annual Meeting. 2003.
- U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans, 2020-2025. https://www.cdc.gov/alcohol/about-alcohol-use/index.html
- Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4 Pt 1):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
- Guo EL, Katta R. Diet and hair loss: effects of nutrient deficiency and supplement use. Dermatol Pract Concept. 2017;7(1):1-10. https://pubmed.ncbi.nlm.nih.gov/28243487/
- McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
- Encourage HE, Barry MJ, Dahm P, et al. Surgical management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA guideline. J Urol. 2018;200(3):612-619. https://pubmed.ncbi.nlm.nih.gov/29775639/
- Fertig RM, Gamret AC, Darwin E, Gaudi S. Sexual side effects of 5-alpha-reductase inhibitors finasteride and dutasteride: a comprehensive review. Dermatol Online J. 2017;23(11). https://pubmed.ncbi.nlm.nih.gov/29447627/
- Endocrine Society. Clinical practice guidelines for testosterone therapy. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/